IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 50.26

Change

+0.17 (+0.34)%

Market Cap

N/A

Volume

0.20M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.39 (-0.28%)

USD 35.08B
FHLC Fidelity® MSCI Health Care In..

-0.20 (-0.31%)

USD 2.50B
FXH First Trust Health Care AlphaD..

-0.56 (-0.56%)

USD 0.89B
XHE SPDR® S&P Health Care Equipme..

-1.45 (-1.80%)

USD 0.16B
IDNA iShares Genomics Immunology an..

-0.15 (-0.71%)

USD 0.10B
XHS SPDR® S&P Health Care Service..

-0.16 (-0.16%)

USD 0.09B
SBIO ALPS Medical Breakthroughs ETF

-0.37 (-1.24%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.18 (-0.66%)

USD 0.04B
BBP Virtus LifeSci Biotech Product..

-0.35 (-0.60%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-0.55 (-2.81%)

USD 0.01B

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 9.23 % 0.00 %

-0.13 (-0.46%)

USD 0.08B
LCR Managed Portfolio Series 0.00 % 0.00 %

+0.05 (+-0.46%)

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.73% 95% A 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.73% 95% A 79% B-
Trailing 12 Months  
Capital Gain -3.29% 33% F 36% F
Dividend Return 0.59% 56% F 9% A-
Total Return -2.70% 33% F 31% F
Trailing 5 Years  
Capital Gain 35.27% 81% B- 49% F
Dividend Return 5.45% 63% D 11% F
Total Return 40.72% 71% C- 40% F
Average Annual (5 Year Horizon)  
Capital Gain 2.76% 62% D 47% F
Dividend Return 3.41% 62% D 41% F
Total Return 0.64% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 19.45% 43% F 52% F
Risk Adjusted Return 17.51% 57% F 36% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.